<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 11/05/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 11/05/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Jordine Szewczyk</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">July 8, 1950 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Declined to Specify</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>100 HAMPTON RD<br/>LOT 265<br/>CLEARWATER, FL 33759-3934, US<br/><br/>Primary Home Phone:  727-953-5850<br/>Mobile Phone:  727-953-5850<br/>Email:  guy7644111@aol.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">46106 2.16.840.1.113883.4.391.327187<br/>46106 2.16.840.1.113883.4.391.327187.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">c75f3507-3197-49a9-b235-b943e964d0f5 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">November 7, 2024, 15:44:52, EST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Scott Kapulskey</td></tr><tr><td class="td_header_role_value internal_format">2780 E BAY DR<br/>LARGO, FL 33771-2469, US<br/><br/>Tel:  727-535-3489<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">21953010 2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From November 5, 2024, 09:40:00   to November 5, 2024, 10:00:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Scott Kapulskey</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">2780 E BAY DR<br/>LARGO, FL 33771-2469, US<br/><br/>Tel:  727-535-3489<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">Scott Szewczy<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">100 Hampton Rd<br/>Lot 265<br/>Clearwater, FL 33759, US<br/><br/>Tel:  727-224-3660<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Jordine Szewczyk<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  727-953-5850<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Scott Kapulskey signed at November 5, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">2780 E BAY DR<br/>LARGO, FL 33771-2469, US<br/><br/>Tel:  727-535-3489<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">MyCare Medical Group</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1785 NORTHPOINTE PKWY<br/>STE 300<br/>LUTZ, FL 33558-5742, US<br/><br/>Tel:  813-536-7277<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Immunizations</a></li><li><a href="#id5">Social History</a></li><li><a href="#id6">Problems</a></li><li><a href="#id7">Vital Signs</a></li><li><a href="#id8">Encounters</a></li><li><a href="#id9">Assessments</a></li><li><a href="#id10">Plan Of Treatment</a></li><li><a href="#id11">Progress Notes</a></li><li><a href="#id12">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">hydromorphone</td><td>Dilaudid</td><td ID="reaction1">aggressive</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy2">risperidone</td><td>RisperDAL</td><td ID="reaction2">forgetfulness and can't have a conversation</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy3"/><td>Adhesive</td><td ID="reaction3">tears skin</td><td>Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>3 month f/u</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Irbesartan 300 MG</td><td ID="instruction1">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Cyanocobalamin 1000 MCG/ML</td><td ID="instruction2">1 mL Injection Weekly for 84 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Rosuvastatin Calcium 40 MG</td><td ID="instruction3">1 tablet Orally Once a day for 90 days</td><td/><td>04/17/2023</td><td/><td>Active</td></tr><tr><td ID="medication4">Prevagen 10 MG</td><td ID="instruction4">as directed Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">ALPRAZolam 0.25 MG</td><td ID="instruction5">1 tablet Orally Twice a day as needed for 30 days</td><td/><td>11/05/2024</td><td/><td>Active</td></tr><tr><td ID="medication6">Ergocalciferol 1.25 MG (50000 UT)</td><td ID="instruction6">1 capsule Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Carvedilol 25 MG</td><td ID="instruction7">1 tablet with food Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">buPROPion HCl ER (XL) 300 MG</td><td ID="instruction8">1 tablet in the morning Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Eliquis 5 MG</td><td ID="instruction9">1 tablet Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Ondansetron 4 MG</td><td ID="instruction10">DISSOLVE ONE TABLET ON TOP OF TONGUE AND ALLOW TO DISSOLVE TWICE DAILY AS NEEDED.</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Lidocaine 5 %</td><td ID="instruction11">1 patch remove after 12 hours Externally Once a day</td><td/><td>03/11/2024</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Immunizations</a></h3><div><table width="100%" border="1"><thead><tr><th>Vaccine</th><th>Route</th><th>Administration Date</th><th>Status</th><th>Comments</th></tr></thead><tbody><tr><td ID="immunization1">FLUAD HD - MCR</td><td>IM Intramuscular</td><td>11/05/2024</td><td>Administered</td><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Female</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>nonsmoker</td><td/></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Major depression in remission (42810003)</td><td ID="Problem1">Major depression in remission (F32.5)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Height</th><td>62 in</td><td>11/05/2024</td></tr><tr><th ID="vital2">Weight</th><td>216 lbs</td><td>11/05/2024</td></tr><tr><th ID="vital3">Weight-kg</th><td>97.98 kg</td><td>11/05/2024</td></tr><tr><th ID="vital4">BMI</th><td>39.5 kg/m2</td><td>11/05/2024</td></tr><tr><th ID="vital5">Blood pressure systolic</th><td>130 mm Hg</td><td>11/05/2024</td></tr><tr><th ID="vital6">Blood pressure diastolic</th><td>80 mm Hg</td><td>11/05/2024</td></tr><tr><th ID="vital7">Heart Rate</th><td>67 /min</td><td>11/05/2024</td></tr><tr><th ID="vital8">Temperature</th><td>98.1 degrees Fahrenheit</td><td>11/05/2024</td></tr><tr><th ID="vital9">Respiratory Rate</th><td>18 /min</td><td>11/05/2024</td></tr><tr><th ID="vital10">Oximetry</th><td>97 %</td><td>11/05/2024</td></tr><tr><td colspan="3"><span class="content_span">Aderholtz-Taylor, Danielle 11/5/2024 09:19:07 AM EST &gt;</span></td></tr></tbody></table></div><h3><a name="id8" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Largo East Bay Dr.</td><td>2780 E BAY DR LARGO, FL 33771-2469</td><td>11/05/2024</td><td>Scott Kapulskey</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.0 ; Chronic systolic (congestive) heart failure I50.22 ; Non-ischemic cardiomyopathy I42.8 ; End stage heart failure I50.84 ; AICD (automatic cardioverter/defibrillator) present Z95.810 ; Encounter for immunization Z23 ; Major depression in remission F32.5 and PANIC ATTACKS F41.0</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">11/05/2024</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I13.0)</td><td>EP note in MPH 2/2023 (CHF with decreased EF)</td><td>Hypertension is under reasonable control.  She has good rate control as well.  Continue the current regimen.  Discussed weight loss, discussed exercise.  The medication also helps with her heart failure and her kidney disease.  </td><td/></tr><tr><td ID="ref2">11/05/2024</td><td>Chronic systolic (congestive) heart failure (ICD-10 - I50.22)</td><td>Pt had non-ischemic cardiomyopathy requiring AICD/advanced pacemaker with epicardial lead 9/2017. LVEF 20-25% with dyssynchronous movement, "severly symptomatic" per CT surgery office note of 9/17/2017. With Goal-directed therapy, the patient now has persistent HF with a mildly supressed EF. Pt was STAGE D</td><td>Clinically compensated.  The patient heart failure symptoms are controlled.  Her performance status is improved from her worst, which placed her stage D at the time</td><td/></tr><tr><td ID="ref3">11/05/2024</td><td>Non-ischemic cardiomyopathy (ICD-10 - I42.8)</td><td><p>2017 diagnosed at cath at MPH with severly depressed EF. </p><p>Pt had non-ischemic cardiomyopathy requiring AICD/advanced pacemaker with epicardial lead 9/2017. LVEF 20-25% with dyssynchronous movement, "severly symptomatic" per CT surgery office note of 9/17/2017. With Goal-directed therapy, the patient now has persistent HF with a mildly supressed EF. Pt was STAGE D</p><p>Currently a ,mildly decreased EF per cardiol, 2/2023, EF 45 to 50%. EF was very suppressed</p></td><td>As noted under assessment.  The patient's stage D symptoms have improved somewhat with goal-directed therapy and a good result.  Controlling rate, blood pressure control are also important components</td><td/></tr><tr><td ID="ref4">11/05/2024</td><td>End stage heart failure (ICD-10 - I50.84)</td><td><p>Pt had non-ischemic cardiomyopathy requiring AICD/advanced pacemaker. With Goal-directed therapy, the patient now has persistent HF with a mildly supressed EF. </p><p>Pt had non-ischemic cardiomyopathy requiring AICD/advanced pacemaker with epicardial lead 9/2017. LVEF 20-25% with dyssynchronous movement, "severly symptomatic" per CT surgery office note of 9/17/2017. With Goal-directed therapy, the patient now has persistent HF with a mildly supressed EF. Pt was STAGE D</p></td><td>As above.  Stage D heart failure improved with goal-directed therapy.  AICD/pacemaker in place</td><td/></tr><tr><td ID="ref5">11/05/2024</td><td>AICD (automatic cardioverter/defibrillator) present (ICD-10 - Z95.810)</td><td>Nonischemic cardiomyopathy with dysrhthmias.</td><td>Placed because of stage D heart failure with significantly depressed ejection fraction and for rhythm disturbances (pacemaker component).  The patient notes no discharges</td><td/></tr><tr><td ID="ref6">11/05/2024</td><td>Encounter for immunization (ICD-10 - Z23)</td><td/><td/><td/></tr><tr><td ID="ref7">11/05/2024</td><td>Major depression in remission (ICD-10 - F32.5)</td><td/><td>Depression is under good control.  The patient is taking a break from health maintenance testing such as mammograms or colonoscopies, and was again reminded of this today.  Suggest she go back on the bupropion if at all possible</td><td/></tr><tr><td ID="ref8">11/05/2024</td><td>PANIC ATTACKS (ICD-10 - F41.0)</td><td/><td>Controlled with medicines.  Suggested counseling (there is an 800-number on the patient's card).  Will switch from the atypical antipsychotic back to the benzodiazepine due to confusion and memory issues from the risperidone.</td><td/></tr><tr><td ID="ref9">11/05/2024</td><td>Other</td><td/><td>Of note, the patient results demonstrate a folic acid deficiency.  I have recommended folic acid 800 mcg twice daily, and continue the B12 for her B12 deficiency.</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Irbesartan 300 MG</td><td>1 tablet Orally Once a day</td><td/><td/><td/></tr><tr><td ID="potMeds2">ALPRAZolam 0.25 MG</td><td>1 tablet Orally Twice a day as needed for 30 days</td><td>11/05/2024</td><td/><td/></tr><tr><td ID="potMeds3">Carvedilol 25 MG</td><td>1 tablet with food Orally Twice a day</td><td/><td/><td/></tr><tr><td ID="potMeds4">buPROPion HCl ER (XL) 300 MG</td><td>1 tablet in the morning Orally Once a day for 90 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td><td>Hypertension is under reasonable control.  She has good rate control as well.  Continue the current regimen.  Discussed weight loss, discussed exercise.  The medication also helps with her heart failure and her kidney disease.  </td></tr><tr><td ID="instructionpot2">Chronic systolic (congestive) heart failure</td><td>Clinically compensated.  The patient heart failure symptoms are controlled.  Her performance status is improved from her worst, which placed her stage D at the time</td></tr><tr><td ID="instructionpot3">Non-ischemic cardiomyopathy</td><td>As noted under assessment.  The patient's stage D symptoms have improved somewhat with goal-directed therapy and a good result.  Controlling rate, blood pressure control are also important components</td></tr><tr><td ID="instructionpot4">End stage heart failure</td><td>As above.  Stage D heart failure improved with goal-directed therapy.  AICD/pacemaker in place</td></tr><tr><td ID="instructionpot5">AICD (automatic cardioverter/defibrillator) present</td><td>Placed because of stage D heart failure with significantly depressed ejection fraction and for rhythm disturbances (pacemaker component).  The patient notes no discharges</td></tr><tr><td ID="instructionpot6">Major depression in remission</td><td>Depression is under good control.  The patient is taking a break from health maintenance testing such as mammograms or colonoscopies, and was again reminded of this today.  Suggest she go back on the bupropion if at all possible</td></tr><tr><td ID="instructionpot7">PANIC ATTACKS</td><td>Controlled with medicines.  Suggested counseling (there is an 800-number on the patient's card).  Will switch from the atypical antipsychotic back to the benzodiazepine due to confusion and memory issues from the risperidone.</td></tr><tr><td ID="instructionpot8">Other</td><td>Of note, the patient results demonstrate a folic acid deficiency.  I have recommended folic acid 800 mcg twice daily, and continue the B12 for her B12 deficiency.</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 3 Months, Reason: Follow-up of chronic conditions</td></tr><tr><td ID="futureAppt1">Provider Name:Scott Kapulskey, 02/05/2025 08:20:00 AM, 2780 E BAY DR, LARGO, FL, 33771-2469, 727-535-3489</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>SZEWCZYK, Jordine <span class="bold">DOB:</span> 07/08/1950 (74 yo F) <span class="bold">Acc No.</span> 46106 <span class="bold">DOS:</span> 11/05/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>SZEWCZYK, Jordine<br/><span class="bold">Account Number: </span>46106</td><td align="right"><span class="bold">Provider: </span>Scott Kapulskey, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>07/08/1950<span class="bold">   Age: </span>74 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>11/05/2024</td></tr><tr><td><span class="bold">Phone: </span>727-953-5850</td></tr><tr><td colspan="2"><span class="bold">Address: </span>100 HAMPTON RD, LOT 265, CLEARWATER, FL-33759-3934</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   3 month f/u</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Depression screening</span>: <br/>       Patient presents in scheduled follow-up.  She has become very forgetful and she is of the belief that it was the risperidone.  She stopped it.  She also misplaced her Wellbutrin about a week ago likely after the second hurricane.<br/><br/>She feels that since stopping the medicine her memory has improved.<br/><br/>Overall she is feeling well.  See review of symptoms.  Labs reviewed in depth.<br/>      PHQ-9 <br/>         Little interest or pleasure in doing things <span class="italics">Several days</span><br/>         Feeling down, depressed, or hopeless <span class="italics">Several days</span><br/>         Trouble falling or staying asleep, or sleeping too much <span class="italics">More than half the days</span><br/>         Feeling tired or having little energy <span class="italics">Several days</span><br/>         Poor appetite or overeating <span class="italics">Not at all</span><br/>         Feeling bad about yourself or that you are a failure, or have let yourself or your family down <span class="italics">Not at all</span><br/>         Trouble concentrating on things, such as reading the newspaper or watching television <span class="italics">Not at all</span><br/>         Moving or speaking so slowly that other people could have noticed; or the opposite, being so fidgety or restless that you have been moving around a lot more than usual <span class="italics">Not at all</span><br/>         Thoughts that you would be better off dead or of hurting yourself in some way <span class="italics">Not at all</span><br/>         Total Score <span class="italics">5</span><br/>         Interpretation <span class="italics">Mild Depression</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General ROS</span>: <br/>      General / Constitutional: patient denies, change in appetite , chills , fever , night sweats. Respiratory: patient denies, cough , hemoptysis , shortness of breath , sputum production , wheezing. Cardiovascular: patient denies, chest pain at rest , chest pain with exertion , difficulty laying flat , dizziness , dyspnea on exertion , fluid accumulation in the legs. Gastrointestinal: patient denies, abdominal pain , blood in stool , change in bowel habits. Genitourinary: patient denies, blood in the urine. Musculoskeletal: patient denies, red or swollen joints. Neurologic: patient denies, confusion , headache. Psychiatric: patient denies, Sleep issues..   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> laparotomy for diverticulitis 2016laprotomy for intestinal obstruction 11/2021Total Right knee replacement 5/2/23</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> Abdominal Surgery 11/21MPH- AICD malfunction 09/08/2022MPH cardiothoracic surgery 02/09/23MCS Gallbladder procedure 8/2023MCH Abdominal pain 3/2024</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased 66 yrs,  diagnosed with Heart disease. Mother: deceased 65 yrs,  diagnosed with Other malignant neoplasm without specification of site. Brother: deceased 44 yrs. 1 son(s) . . <br/>brother died of hodgkins disease<br/>sister died of colon cancer.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Use/Smoking <br/>         Tobacco use: <span class="italics">nonsmoker</span><br/>   <span class="Underline">Drugs/Alcohol:</span> <br/>       Alcohol Screen (Audit-C) <br/>         Did you have a drink containing alcohol in the past year? <span class="italics">No</span><br/>         Points <span class="italics">0</span><br/>         Interpretation <span class="italics">Negative</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingRosuvastatin Calcium 40 MG Tablet 1 tablet Orally Once a day Prevagen 10 MG Capsule as directed Orally Once a day Lidocaine 5 % Patch 1 patch remove after 12 hours Externally Once a day Ondansetron 4 MG Tablet Disintegrating DISSOLVE ONE TABLET ON TOP OF TONGUE AND ALLOW TO DISSOLVE TWICE DAILY AS NEEDED.   Ergocalciferol 1.25 MG (50000 UT) Capsule 1 capsule Orally Once a day Eliquis 5 MG Tablet 1 tablet Orally Twice a day Carvedilol 25 MG Tablet 1 tablet with food Orally Twice a day Irbesartan 300 MG Tablet 1 tablet Orally Once a day Cyanocobalamin 1000 MCG/ML Solution 1 mL Injection Weekly Taking Rosuvastatin Calcium 40 MG Tablet 1 tablet Orally Once a day Taking Prevagen 10 MG Capsule as directed Orally Once a day Taking Lidocaine 5 % Patch 1 patch remove after 12 hours Externally Once a day Taking Ondansetron 4 MG Tablet Disintegrating DISSOLVE ONE TABLET ON TOP OF TONGUE AND ALLOW TO DISSOLVE TWICE DAILY AS NEEDED.   Taking Ergocalciferol 1.25 MG (50000 UT) Capsule 1 capsule Orally Once a day Taking Eliquis 5 MG Tablet 1 tablet Orally Twice a day Taking Carvedilol 25 MG Tablet 1 tablet with food Orally Twice a day Taking Irbesartan 300 MG Tablet 1 tablet Orally Once a day Taking Cyanocobalamin 1000 MCG/ML Solution 1 mL Injection Weekly Not-TakingbuPROPion HCl ER (XL) 300 MG Tablet Extended Release 24 Hour 1 tablet in the morning Orally Once a day Not-Taking buPROPion HCl ER (XL) 300 MG Tablet Extended Release 24 Hour 1 tablet in the morning Orally Once a day DiscontinuedrisperiDONE 0.5 MG Tablet 1 tablet Orally at bedtime for depression and sleep Medication List reviewed and reconciled with the patientDiscontinued risperiDONE 0.5 MG Tablet 1 tablet Orally at bedtime for depression and sleep Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Dilaudid: aggressive - Side EffectsAdhesive: tears skin - Side EffectsRisperDAL: forgetfulness and can't have a conversation - Side Effectsno[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 62 in, Wt: <span class="bold">216</span> lbs, Wt-kg: 97.98 kg, BMI: <span class="bold">39.5</span> Index, BP: <span class="bold">130/80</span> mm Hg, HR: <span class="bold">67</span> /min, Temp: <span class="bold">98.1</span> F, RR: <span class="bold">18</span> /min, Oxygen sat %: <span class="bold">97</span> %, Body Surface Area: 2.07.<br/><span class="content_span">Aderholtz-Taylor, Danielle 11/5/2024 09:19:07 AM EST &gt;</span>.</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:Vitamin B12 and Folate-000810</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">11:18 AM</td><td align="left">10:30 AM</td><td align="left">08:51 AM</td><td align="left">07:31 AM</td></tr><tr><td align="left">Order Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td></tr><tr><td align="left">Vitamin B12</td><td class="bold" align="left">1382    H<br/>(Ref Range: 232-1245 pg/mL)</td><td class="bold" align="left">&gt;2000    H<br/>(Ref Range: 232-1245 pg/mL)</td><td class="bold" align="left">&gt;2000    H<br/>(Ref Range: 232-1245 pg/mL)</td><td class="bold" align="left">1332    H<br/>(Ref Range: 232-1245 pg/mL)</td></tr><tr><td align="left">Folate (Folic Acid), Serum</td><td class="bold" align="left">2.4    L<br/>(Ref Range: &gt;3.0 ng/mL)</td><td align="left">4.3<br/>(Ref Range: &gt;3.0 ng/mL)</td><td align="left">3.1<br/>(Ref Range: &gt;3.0 ng/mL)</td><td class="bold" align="left">2.3    L<br/>(Ref Range: &gt;3.0 ng/mL)</td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">Kapulskey, Scott 6/20/2024 07:58:46 AM EDT &gt;  Kapulskey, Scott 6/20/2024 07:59:15 AM EDT &gt;</td><td align="left">Kapulskey, Scott 3/20/2024 02:30:27 PM EDT &gt;</td><td align="left">Kapulskey, Scott 12/20/2023 07:35:54 AM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:Iron and TIBC-001321</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">11/01/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">11:18 AM</td><td align="left">07:31 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">11/01/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Iron Bind.Cap.(TIBC)</td><td align="left">296<br/>(Ref Range: 250-450 ug/dL)</td><td align="left">326<br/>(Ref Range: 250-450 ug/dL)</td><td align="left">325<br/>(Ref Range: 250-450 ug/dL)</td></tr><tr><td align="left">UIBC</td><td align="left">256<br/>(Ref Range: 118-369 ug/dL)</td><td align="left">281<br/>(Ref Range: 118-369 ug/dL)</td><td align="left">277<br/>(Ref Range: 118-369 ug/dL)</td></tr><tr><td align="left">Iron</td><td align="left">40<br/>(Ref Range: 27-139 ug/dL)</td><td align="left">45<br/>(Ref Range: 27-139 ug/dL)</td><td align="left">48<br/>(Ref Range: 27-139 ug/dL)</td></tr><tr><td align="left">Iron Saturation</td><td class="bold" align="left">14    L<br/>(Ref Range: 15-55 %)</td><td class="bold" align="left">14    L<br/>(Ref Range: 15-55 %)</td><td align="left">15<br/>(Ref Range: 15-55 %)</td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">Kapulskey, Scott 12/20/2023 07:35:54 AM &gt;</td><td align="left">Kapulskey, Scott 8/18/2023 03:20:50 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:Hemoglobin A1c-001453</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">04/05/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">11:18 AM</td><td align="left">10:30 AM</td><td align="left">08:51 AM</td><td align="left">07:31 AM</td><td align="left">12:01 PM</td></tr><tr><td align="left">Order Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">04/05/2023</td></tr><tr><td align="left">Hemoglobin A1c</td><td align="left">5.1<br/>(Ref Range: 4.8-5.6 %)</td><td align="left">5.5<br/>(Ref Range: 4.8-5.6 %)</td><td align="left">5.2<br/>(Ref Range: 4.8-5.6 %)</td><td align="left">5.0<br/>(Ref Range: 4.8-5.6 %)</td><td align="left">5.4<br/>(Ref Range: 4.8-5.6 %)</td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">Kapulskey, Scott 6/20/2024 07:58:46 AM EDT &gt;  Kapulskey, Scott 6/20/2024 07:59:15 AM EDT &gt;</td><td align="left">Kapulskey, Scott 3/20/2024 02:30:27 PM EDT &gt;</td><td align="left">Kapulskey, Scott 12/20/2023 07:35:54 AM &gt;</td><td align="left">Kapulskey, Scott 4/10/2023 07:48:49 AM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:TSH-004259</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">11:18 AM</td><td align="left">10:30 AM</td><td align="left">08:51 AM</td><td align="left">07:31 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">TSH</td><td align="left">1.390<br/>(Ref Range: 0.450-4.500 uIU/mL)</td><td align="left">1.280<br/>(Ref Range: 0.450-4.500 uIU/mL)</td><td align="left">1.170<br/>(Ref Range: 0.450-4.500 uIU/mL)</td><td align="left">1.500<br/>(Ref Range: 0.450-4.500 uIU/mL)</td><td align="left">1.600<br/>(Ref Range: 0.450-4.500 uIU/mL)</td></tr><tr><td align="left">Request Problem</td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">TNP<br/></td><td align="left">NR<br/></td><td align="left">NR<br/></td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">Kapulskey, Scott 6/20/2024 07:58:46 AM EDT &gt;  Kapulskey, Scott 6/20/2024 07:59:15 AM EDT &gt;</td><td align="left">Kapulskey, Scott 3/20/2024 02:30:27 PM EDT &gt;</td><td align="left">Kapulskey, Scott 12/20/2023 07:35:54 AM &gt;</td><td align="left">Kapulskey, Scott 8/18/2023 03:20:50 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:Ferritin-004598</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">11/01/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">11:18 AM</td><td align="left">07:31 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">11/01/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Ferritin</td><td align="left">80<br/>(Ref Range: 15-150 ng/mL)</td><td align="left">104<br/>(Ref Range: 15-150 ng/mL)</td><td align="left">117<br/>(Ref Range: 15-150 ng/mL)</td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">Kapulskey, Scott 12/20/2023 07:35:54 AM &gt;</td><td align="left">Kapulskey, Scott 8/18/2023 03:20:50 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CBC With Differential/Platelet-005009</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">11:18 AM</td><td align="left">10:30 AM</td><td align="left">08:51 AM</td><td align="left">07:31 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">WBC</td><td align="left">8.5<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">6.3<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">6.3<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">6.0<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">5.8<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td></tr><tr><td align="left">RBC</td><td align="left">4.78<br/>(Ref Range: 3.77-5.28 x10E6/uL)</td><td align="left">5.22<br/>(Ref Range: 3.77-5.28 x10E6/uL)</td><td align="left">4.65<br/>(Ref Range: 3.77-5.28 x10E6/uL)</td><td align="left">4.76<br/>(Ref Range: 3.77-5.28 x10E6/uL)</td><td align="left">4.46<br/>(Ref Range: 3.77-5.28 x10E6/uL)</td></tr><tr><td align="left">Hemoglobin</td><td align="left">13.8<br/>(Ref Range: 11.1-15.9 g/dL)</td><td align="left">14.4<br/>(Ref Range: 11.1-15.9 g/dL)</td><td align="left">13.6<br/>(Ref Range: 11.1-15.9 g/dL)</td><td align="left">14.1<br/>(Ref Range: 11.1-15.9 g/dL)</td><td align="left">13.0<br/>(Ref Range: 11.1-15.9 g/dL)</td></tr><tr><td align="left">Hematocrit</td><td align="left">41.8<br/>(Ref Range: 34.0-46.6 %)</td><td align="left">43.7<br/>(Ref Range: 34.0-46.6 %)</td><td align="left">40.9<br/>(Ref Range: 34.0-46.6 %)</td><td align="left">41.8<br/>(Ref Range: 34.0-46.6 %)</td><td align="left">39.8<br/>(Ref Range: 34.0-46.6 %)</td></tr><tr><td align="left">MCV</td><td align="left">87<br/>(Ref Range: 79-97 fL)</td><td align="left">84<br/>(Ref Range: 79-97 fL)</td><td align="left">88<br/>(Ref Range: 79-97 fL)</td><td align="left">88<br/>(Ref Range: 79-97 fL)</td><td align="left">89<br/>(Ref Range: 79-97 fL)</td></tr><tr><td align="left">MCH</td><td align="left">28.9<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">27.6<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">29.2<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">29.6<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">29.1<br/>(Ref Range: 26.6-33.0 pg)</td></tr><tr><td align="left">MCHC</td><td align="left">33.0<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">33.0<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">33.3<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">33.7<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">32.7<br/>(Ref Range: 31.5-35.7 g/dL)</td></tr><tr><td align="left">RDW</td><td align="left">13.0<br/>(Ref Range: 11.7-15.4 %)</td><td align="left">12.9<br/>(Ref Range: 11.7-15.4 %)</td><td align="left">12.6<br/>(Ref Range: 11.7-15.4 %)</td><td class="bold" align="left">15.6    H<br/>(Ref Range: 11.7-15.4 %)</td><td align="left">14.0<br/>(Ref Range: 11.7-15.4 %)</td></tr><tr><td align="left">Platelets</td><td align="left">242<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">201<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">247<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">219<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">219<br/>(Ref Range: 150-450 x10E3/uL)</td></tr><tr><td align="left">Neutrophils</td><td align="left">78<br/>(Ref Range: Not Estab. %)</td><td align="left">70<br/>(Ref Range: Not Estab. %)</td><td align="left">73<br/>(Ref Range: Not Estab. %)</td><td align="left">72<br/>(Ref Range: Not Estab. %)</td><td align="left">71<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Lymphs</td><td align="left">11<br/>(Ref Range: Not Estab. %)</td><td align="left">17<br/>(Ref Range: Not Estab. %)</td><td align="left">14<br/>(Ref Range: Not Estab. %)</td><td align="left">16<br/>(Ref Range: Not Estab. %)</td><td align="left">15<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Monocytes</td><td align="left">7<br/>(Ref Range: Not Estab. %)</td><td align="left">9<br/>(Ref Range: Not Estab. %)</td><td align="left">9<br/>(Ref Range: Not Estab. %)</td><td align="left">9<br/>(Ref Range: Not Estab. %)</td><td align="left">9<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Eos</td><td align="left">3<br/>(Ref Range: Not Estab. %)</td><td align="left">2<br/>(Ref Range: Not Estab. %)</td><td align="left">3<br/>(Ref Range: Not Estab. %)</td><td align="left">2<br/>(Ref Range: Not Estab. %)</td><td align="left">3<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Basos</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Neutrophils (Absolute)</td><td align="left">6.7<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.4<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.5<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.3<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.2<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td></tr><tr><td align="left">Lymphs (Absolute)</td><td align="left">1.0<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.1<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">0.9<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.0<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">0.9<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td></tr><tr><td align="left">Monocytes(Absolute)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.5<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.5<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td></tr><tr><td align="left">Eos (Absolute)</td><td align="left">0.2<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.2<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.2<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.2<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td></tr><tr><td align="left">Baso (Absolute)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td></tr><tr><td align="left">Immature Granulocytes</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Immature Grans (Abs)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">Kapulskey, Scott 6/20/2024 07:58:46 AM EDT &gt;  Kapulskey, Scott 6/20/2024 07:59:15 AM EDT &gt;</td><td align="left">Kapulskey, Scott 3/20/2024 02:30:27 PM EDT &gt;</td><td align="left">Kapulskey, Scott 12/20/2023 07:35:54 AM &gt;</td><td align="left">Kapulskey, Scott 8/18/2023 03:20:50 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:Lipid Panel-303756</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">11:18 AM</td><td align="left">10:30 AM</td><td align="left">08:51 AM</td><td align="left">07:31 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Cholesterol, Total</td><td align="left">187<br/>(Ref Range: 100-199 mg/dL)</td><td class="bold" align="left">216    H<br/>(Ref Range: 100-199 mg/dL)</td><td align="left">188<br/>(Ref Range: 100-199 mg/dL)</td><td class="bold" align="left">221    H<br/>(Ref Range: 100-199 mg/dL)</td><td class="bold" align="left">201    H<br/>(Ref Range: 100-199 mg/dL)</td></tr><tr><td align="left">Triglycerides</td><td align="left">90<br/>(Ref Range: 0-149 mg/dL)</td><td align="left">72<br/>(Ref Range: 0-149 mg/dL)</td><td align="left">76<br/>(Ref Range: 0-149 mg/dL)</td><td align="left">74<br/>(Ref Range: 0-149 mg/dL)</td><td align="left">85<br/>(Ref Range: 0-149 mg/dL)</td></tr><tr><td align="left">HDL Cholesterol</td><td align="left">51<br/>(Ref Range: &gt;39 mg/dL)</td><td align="left">59<br/>(Ref Range: &gt;39 mg/dL)</td><td align="left">54<br/>(Ref Range: &gt;39 mg/dL)</td><td align="left">69<br/>(Ref Range: &gt;39 mg/dL)</td><td align="left">56<br/>(Ref Range: &gt;39 mg/dL)</td></tr><tr><td align="left">VLDL Cholesterol Cal</td><td align="left">16<br/>(Ref Range: 5-40 mg/dL)</td><td align="left">13<br/>(Ref Range: 5-40 mg/dL)</td><td align="left">14<br/>(Ref Range: 5-40 mg/dL)</td><td align="left">13<br/>(Ref Range: 5-40 mg/dL)</td><td align="left">15<br/>(Ref Range: 5-40 mg/dL)</td></tr><tr><td align="left">LDL Chol Calc (NIH)</td><td class="bold" align="left">120    H<br/>(Ref Range: 0-99 mg/dL)</td><td class="bold" align="left">144    H<br/>(Ref Range: 0-99 mg/dL)</td><td class="bold" align="left">120    H<br/>(Ref Range: 0-99 mg/dL)</td><td class="bold" align="left">139    H<br/>(Ref Range: 0-99 mg/dL)</td><td class="bold" align="left">130    H<br/>(Ref Range: 0-99 mg/dL)</td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">Kapulskey, Scott 6/20/2024 07:58:46 AM EDT &gt;  Kapulskey, Scott 6/20/2024 07:59:15 AM EDT &gt;</td><td align="left">Kapulskey, Scott 3/20/2024 02:30:27 PM EDT &gt;</td><td align="left">Kapulskey, Scott 12/20/2023 07:35:54 AM &gt;</td><td align="left">Kapulskey, Scott 8/18/2023 03:20:50 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:Comp. Metabolic Panel (14)-322000</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">11:18 AM</td><td align="left">10:30 AM</td><td align="left">08:51 AM</td><td align="left">07:31 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Glucose</td><td class="bold" align="left">108    H<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">85<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">89<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">99<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">87<br/>(Ref Range: 70-99 mg/dL)</td></tr><tr><td align="left">BUN</td><td align="left">17<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">22<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">15<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">20<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">24<br/>(Ref Range: 8-27 mg/dL)</td></tr><tr><td align="left">Sodium</td><td align="left">139<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">138<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">139<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">140<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">138<br/>(Ref Range: 134-144 mmol/L)</td></tr><tr><td align="left">BUN/Creatinine Ratio</td><td align="left">18<br/>(Ref Range: 12-28)</td><td align="left">22<br/>(Ref Range: 12-28)</td><td align="left">14<br/>(Ref Range: 12-28)</td><td align="left">19<br/>(Ref Range: 12-28)</td><td align="left">23<br/>(Ref Range: 12-28)</td></tr><tr><td align="left">Chloride</td><td align="left">103<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">102<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">102<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">103<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">103<br/>(Ref Range: 96-106 mmol/L)</td></tr><tr><td align="left">Potassium</td><td align="left">4.3<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.6<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.0<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.1<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.6<br/>(Ref Range: 3.5-5.2 mmol/L)</td></tr><tr><td align="left">Calcium</td><td align="left">9.5<br/>(Ref Range: 8.7-10.3 mg/dL)</td><td align="left">9.8<br/>(Ref Range: 8.7-10.3 mg/dL)</td><td align="left">9.3<br/>(Ref Range: 8.7-10.3 mg/dL)</td><td align="left">9.8<br/>(Ref Range: 8.7-10.3 mg/dL)</td><td align="left">9.8<br/>(Ref Range: 8.7-10.3 mg/dL)</td></tr><tr><td align="left">Protein, Total</td><td align="left">6.0<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.5<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.3<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.5<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.4<br/>(Ref Range: 6.0-8.5 g/dL)</td></tr><tr><td align="left">Albumin</td><td align="left">4.2<br/>(Ref Range: 3.8-4.8 g/dL)</td><td align="left">4.4<br/>(Ref Range: 3.8-4.8 g/dL)</td><td align="left">4.1<br/>(Ref Range: 3.8-4.8 g/dL)</td><td align="left">4.5<br/>(Ref Range: 3.8-4.8 g/dL)</td><td align="left">4.4<br/>(Ref Range: 3.8-4.8 g/dL)</td></tr><tr><td align="left">Globulin, Total</td><td align="left">1.8<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.1<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.2<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.0<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.0<br/>(Ref Range: 1.5-4.5 g/dL)</td></tr><tr><td align="left">A/G Ratio</td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">1.9<br/>(Ref Range: 1.2-2.2)</td><td class="bold" align="left">2.3    H<br/>(Ref Range: 1.2-2.2)</td><td align="left">2.2<br/>(Ref Range: 1.2-2.2)</td></tr><tr><td align="left">Bilirubin, Total</td><td align="left">0.6<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.5<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.6<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.6<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.4<br/>(Ref Range: 0.0-1.2 mg/dL)</td></tr><tr><td align="left">Alkaline Phosphatase</td><td class="bold" align="left">138    H<br/>(Ref Range: 44-121 IU/L)</td><td class="bold" align="left">142    H<br/>(Ref Range: 44-121 IU/L)</td><td class="bold" align="left">140    H<br/>(Ref Range: 44-121 IU/L)</td><td align="left">117<br/>(Ref Range: 44-121 IU/L)</td><td class="bold" align="left">125    H<br/>(Ref Range: 44-121 IU/L)</td></tr><tr><td align="left">AST (SGOT)</td><td align="left">19<br/>(Ref Range: 0-40 IU/L)</td><td align="left">18<br/>(Ref Range: 0-40 IU/L)</td><td align="left">16<br/>(Ref Range: 0-40 IU/L)</td><td align="left">16<br/>(Ref Range: 0-40 IU/L)</td><td align="left">20<br/>(Ref Range: 0-40 IU/L)</td></tr><tr><td align="left">ALT (SGPT)</td><td align="left">16<br/>(Ref Range: 0-32 IU/L)</td><td align="left">14<br/>(Ref Range: 0-32 IU/L)</td><td align="left">12<br/>(Ref Range: 0-32 IU/L)</td><td align="left">11<br/>(Ref Range: 0-32 IU/L)</td><td align="left">16<br/>(Ref Range: 0-32 IU/L)</td></tr><tr><td align="left">eGFR</td><td align="left">62<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">60<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td class="bold" align="left">55    L<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td class="bold" align="left">56    L<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td class="bold" align="left">57    L<br/>(Ref Range: &gt;59 mL/min/1.73)</td></tr><tr><td align="left">Creatinine</td><td align="left">0.96<br/>(Ref Range: 0.57-1.00 mg/dL)</td><td align="left">0.99<br/>(Ref Range: 0.57-1.00 mg/dL)</td><td class="bold" align="left">1.07    H<br/>(Ref Range: 0.57-1.00 mg/dL)</td><td class="bold" align="left">1.05    H<br/>(Ref Range: 0.57-1.00 mg/dL)</td><td class="bold" align="left">1.03    H<br/>(Ref Range: 0.57-1.00 mg/dL)</td></tr><tr><td align="left">Carbon Dioxide, Total</td><td align="left">22<br/>(Ref Range: 20-29 mmol/L)</td><td class="bold" align="left">19    L<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">22<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">22<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">22<br/>(Ref Range: 20-29 mmol/L)</td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">Kapulskey, Scott 6/20/2024 07:58:46 AM EDT &gt;  Kapulskey, Scott 6/20/2024 07:59:15 AM EDT &gt;</td><td align="left">Kapulskey, Scott 3/20/2024 02:30:27 PM EDT &gt;</td><td align="left">Kapulskey, Scott 12/20/2023 07:35:54 AM &gt;</td><td align="left">Kapulskey, Scott 8/18/2023 03:20:50 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:UA/M w/rflx Culture, Routine-377036</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">11:18 AM</td><td align="left">10:30 AM</td><td align="left">08:51 AM</td><td align="left">07:31 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">11/01/2024</td><td align="left">06/18/2024</td><td align="left">03/19/2024</td><td align="left">12/19/2023</td><td align="left">08/17/2023</td></tr><tr><td align="left">Specific Gravity</td><td align="left">1.013<br/>(Ref Range: 1.005-1.030)</td><td align="left">1.018<br/>(Ref Range: 1.005-1.030)</td><td align="left">TNP<br/></td><td class="bold" align="left">&gt;=1.030    A<br/>(Ref Range: 1.005-1.030)</td><td class="bold" align="left">&gt;=1.030    A<br/>(Ref Range: 1.005-1.030)</td></tr><tr><td align="left">pH</td><td align="left">5.5<br/>(Ref Range: 5.0-7.5)</td><td align="left">5.5<br/>(Ref Range: 5.0-7.5)</td><td align="left">TNP<br/></td><td align="left">5.5<br/>(Ref Range: 5.0-7.5)</td><td align="left">5.0<br/>(Ref Range: 5.0-7.5)</td></tr><tr><td align="left">Urine-Color</td><td align="left">Yellow<br/>(Ref Range: Yellow)</td><td align="left">Yellow<br/>(Ref Range: Yellow)</td><td align="left">NR<br/></td><td align="left">Yellow<br/>(Ref Range: Yellow)</td><td align="left">Yellow<br/>(Ref Range: Yellow)</td></tr><tr><td align="left">Appearance</td><td align="left">Clear<br/>(Ref Range: Clear)</td><td align="left">Clear<br/>(Ref Range: Clear)</td><td align="left">NR<br/></td><td class="bold" align="left">Turbid    A<br/>(Ref Range: Clear)</td><td class="bold" align="left">Cloudy    A<br/>(Ref Range: Clear)</td></tr><tr><td align="left">WBC Esterase</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">NR<br/></td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td></tr><tr><td align="left">Protein</td><td align="left">Negative<br/>(Ref Range: Negative/Trace)</td><td align="left">Negative<br/>(Ref Range: Negative/Trace)</td><td align="left">TNP<br/></td><td class="bold" align="left">2+    A<br/>(Ref Range: Negative/Trace)</td><td align="left">Trace<br/>(Ref Range: Negative/Trace)</td></tr><tr><td align="left">Glucose</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">TNP<br/></td><td class="bold" align="left">Trace    A<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td></tr><tr><td align="left">Ketones</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">TNP<br/></td><td class="bold" align="left">Trace    A<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td></tr><tr><td align="left">Occult Blood</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">NR<br/></td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td></tr><tr><td align="left">Bilirubin</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">NR<br/></td><td align="left">TNP<br/></td><td align="left">Negative<br/>(Ref Range: Negative)</td></tr><tr><td align="left">Urobilinogen,Semi-Qn</td><td align="left">0.2<br/>(Ref Range: 0.2-1.0 mg/dL)</td><td align="left">0.2<br/>(Ref Range: 0.2-1.0 mg/dL)</td><td align="left">NR<br/></td><td align="left">1.0<br/>(Ref Range: 0.2-1.0 mg/dL)</td><td align="left">0.2<br/>(Ref Range: 0.2-1.0 mg/dL)</td></tr><tr><td align="left">Nitrite, Urine</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">NR<br/></td><td align="left">Negative<br/>(Ref Range: Negative)</td><td align="left">Negative<br/>(Ref Range: Negative)</td></tr><tr><td align="left">Microscopic Examination</td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">See below:<br/></td><td align="left">NR<br/></td></tr><tr><td align="left">WBC</td><td align="left">0-5<br/>(Ref Range: 0 -  5 /hpf)</td><td align="left">None seen<br/>(Ref Range: 0 -  5 /hpf)</td><td align="left">NR<br/></td><td align="left">None seen<br/>(Ref Range: 0 -  5 /hpf)</td><td align="left">0-5<br/>(Ref Range: 0 -  5 /hpf)</td></tr><tr><td align="left">RBC</td><td align="left">0-2<br/>(Ref Range: 0 -  2 /hpf)</td><td align="left">None seen<br/>(Ref Range: 0 -  2 /hpf)</td><td align="left">NR<br/></td><td class="bold" align="left">11-30    A<br/>(Ref Range: 0 -  2 /hpf)</td><td class="bold" align="left">3-10    A<br/>(Ref Range: 0 -  2 /hpf)</td></tr><tr><td align="left">Epithelial Cells (non renal)</td><td align="left">0-10<br/>(Ref Range: 0 - 10 /hpf)</td><td class="bold" align="left">&gt;10    A<br/>(Ref Range: 0 - 10 /hpf)</td><td align="left">NR<br/></td><td class="bold" align="left">&gt;10    A<br/>(Ref Range: 0 - 10 /hpf)</td><td class="bold" align="left">&gt;10    A<br/>(Ref Range: 0 - 10 /hpf)</td></tr><tr><td align="left">Casts</td><td align="left">None seen<br/>(Ref Range: None seen /lpf)</td><td align="left">None seen<br/>(Ref Range: None seen /lpf)</td><td align="left">NR<br/></td><td align="left">None seen<br/>(Ref Range: None seen /lpf)</td><td align="left">None seen<br/>(Ref Range: None seen /lpf)</td></tr><tr><td align="left">Mucus Threads</td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">Present<br/>(Ref Range: Not Estab.)</td></tr><tr><td align="left">Bacteria</td><td align="left">None seen<br/>(Ref Range: None seen/Few)</td><td align="left">None seen<br/>(Ref Range: None seen/Few)</td><td align="left">NR<br/></td><td align="left">Few<br/>(Ref Range: None seen/Few)</td><td align="left">Few<br/>(Ref Range: None seen/Few)</td></tr><tr><td align="left">Yeast</td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">NR<br/></td><td class="bold" align="left">Present    A<br/>(Ref Range: None seen)</td></tr><tr><td align="left">Microscopic Examination</td><td align="left">See below:<br/></td><td align="left">See below:<br/></td><td align="left">NR<br/></td><td align="left">NR<br/></td><td align="left">See below:<br/></td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">Kapulskey, Scott 6/20/2024 07:58:46 AM EDT &gt;  Kapulskey, Scott 6/20/2024 07:59:15 AM EDT &gt;</td><td align="left">Kapulskey, Scott 3/20/2024 02:30:27 PM EDT &gt;</td><td align="left">Kapulskey, Scott 12/20/2023 07:35:54 AM &gt;</td><td align="left">Kapulskey, Scott 8/18/2023 03:20:50 PM &gt;</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: alert, pleasant, obese and nourished and in no acute distress, cries easily. <br/>      HEENT Extraocular movements are intact.  Conjunctive a pink and moist. <br/>      Neck / thyroid: supple, no cervical lymphadenopathy , carotid pulses are normal and without bruits. <br/>      Heart: regular rate and rhythm without murmurs, gallops, clicks or rubs. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Abdomen: soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly. <br/>      Neurologic: normal upper and lower extremity motor strength and function, cooperative with exam, arises from a chair and initiates gait in a stable fashion.. <br/>      Back: Left-sided hematoma in the posterior axillary line, also seen along the same line in the left iliac crest from the fall. <br/>      Musculoskeletal: Heberden's nodes of the DIP of the hands  bilaterally.<br/>Decreased range of motion with abduction and internal rotation of the shoulders left greater than right.. <br/>      Head: normocephalic, atraumatic. <br/>      Psych: cooperative with exam, with good judgement and insight, with no auditory or visual hallucinations, thought process is logical and goal directed without suicidal ideation or delusions.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease - I13.0 (Primary)   <content><span class="bold">Notes : </span>EP note in MPH 2/2023 (CHF with decreased EF)</content>   2. Chronic systolic (congestive) heart failure - I50.22   <content><span class="bold">Notes : </span>Pt had non-ischemic cardiomyopathy requiring AICD/advanced pacemaker with epicardial lead 9/2017. LVEF 20-25% with dyssynchronous movement, "severly symptomatic" per CT surgery office note of 9/17/2017. With Goal-directed therapy, the patient now has persistent HF with a mildly supressed EF. Pt was STAGE D</content>   3. Non-ischemic cardiomyopathy - I42.8   <content><span class="bold">Notes : </span>2017 diagnosed at cath at MPH with severly depressed EF.Pt had non-ischemic cardiomyopathy requiring AICD/advanced pacemaker with epicardial lead 9/2017. LVEF 20-25% with dyssynchronous movement, "severly symptomatic" per CT surgery office note of 9/17/2017. With Goal-directed therapy, the patient now has persistent HF with a mildly supressed EF. Pt was STAGE DCurrently a ,mildly decreased EF per cardiol, 2/2023, EF 45 to 50%. EF was very suppressed</content>   4. End stage heart failure - I50.84   <content><span class="bold">Notes : </span>Pt had non-ischemic cardiomyopathy requiring AICD/advanced pacemaker. With Goal-directed therapy, the patient now has persistent HF with a mildly supressed EF.Pt had non-ischemic cardiomyopathy requiring AICD/advanced pacemaker with epicardial lead 9/2017. LVEF 20-25% with dyssynchronous movement, "severly symptomatic" per CT surgery office note of 9/17/2017. With Goal-directed therapy, the patient now has persistent HF with a mildly supressed EF. Pt was STAGE D</content>   5. AICD (automatic cardioverter/defibrillator) present - Z95.810   <content><span class="bold">Notes : </span>Nonischemic cardiomyopathy with dysrhthmias.</content>   6. Encounter for immunization - Z23   7. Major depression in remission - F32.5   8. PANIC ATTACKS - F41.0   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span> <br/>Continue Carvedilol Tablet, 25 MG, 1 tablet with food, Orally, Twice a day; Continue Irbesartan Tablet, 300 MG, 1 tablet, Orally, Once a day.  <br/>Notes: Hypertension is under reasonable control.  She has good rate control as well.  Continue the current regimen.  Discussed weight loss, discussed exercise.  The medication also helps with her heart failure and her kidney disease.    </td></tr><tr><td/></tr><tr><td><span class="bold">2. Chronic systolic (congestive) heart failure</span> <br/>Notes: Clinically compensated.  The patient heart failure symptoms are controlled.  Her performance status is improved from her worst, which placed her stage D at the time  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Non-ischemic cardiomyopathy</span> <br/>Notes: As noted under assessment.  The patient's stage D symptoms have improved somewhat with goal-directed therapy and a good result.  Controlling rate, blood pressure control are also important components  </td></tr><tr><td/></tr><tr><td><span class="bold">4. End stage heart failure</span> <br/>Notes: As above.  Stage D heart failure improved with goal-directed therapy.  AICD/pacemaker in place  </td></tr><tr><td/></tr><tr><td><span class="bold">5. AICD (automatic cardioverter/defibrillator) present</span> <br/>Notes: Placed because of stage D heart failure with significantly depressed ejection fraction and for rhythm disturbances (pacemaker component).  The patient notes no discharges  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Major depression in remission</span> <br/>Continue buPROPion HCl ER (XL) Tablet Extended Release 24 Hour, 300 MG, 1 tablet in the morning, Orally, Once a day, 90 days, 90 Tablet, Refills 3.  <br/>Notes: Depression is under good control.  The patient is taking a break from health maintenance testing such as mammograms or colonoscopies, and was again reminded of this today.  Suggest she go back on the bupropion if at all possible  </td></tr><tr><td/></tr><tr><td><span class="bold">7. PANIC ATTACKS</span> <br/>Continue ALPRAZolam Tablet, 0.25 MG, 1 tablet, Orally, Twice a day as needed, 30 days, 30 Tablet, Refills 2.  <br/>Notes: Controlled with medicines.  Suggested counseling (there is an 800-number on the patient's card).  Will switch from the atypical antipsychotic back to the benzodiazepine due to confusion and memory issues from the risperidone.  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Others </span> <br/>Notes: Of note, the patient results demonstrate a folic acid deficiency.  I have recommended folic acid 800 mcg twice daily, and continue the B12 for her B12 deficiency.  </td></tr><tr><td/></tr><ul><li><table border="1"><tbody><tr><td><span class="bold">Prescription Drug Monitoring Program (PDMP)</span></td></tr><tr><td>PDMP report request completed on  11/05/2024 01:09:24 PM - Kapulskey, Scott</td></tr></tbody></table></li></ul></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Immunizations:</span>    <br/>FLUAD HD - MCR : 0.5 mL (Dose No:1) (Route: Intramuscular) given by Danielle Aderholtz-Taylor on Left Deltoid (Encounter for immunization)</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 1159F MED LIST DOCD IN RCRD1160F RVW MEDS BY RX/DR IN RCRD3075F SYST BP GE 130 - 139MM HG3079F DIAST BP 80-89 MM HGG9903 Pt scrn tbco id as non userG8417 BMI &gt;=30 CALCUATE W/FOLLOWUP90653 FLUAD HD - MCRGCFLU FLU GIFTCARD, Units: 10.00  G0008 ADMN FLU VAC NO FEE SCHED SAME DAY</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 3 Months (Reason: Follow-up of chronic conditions)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. <br/>3075F SYST BP GE 130 - 139MM HG. <br/>3079F DIAST BP 80-89 MM HG. <br/>G9903 Pt scrn tbco id as non user. <br/>G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP. <br/>90653 FLUAD HD - MCR. <br/>GCFLU FLU GIFTCARD. Units: 10.00.  <br/>G0008 ADMN FLU VAC NO FEE SCHED SAME DAY. </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by Scott Kapulskey , MD, ME108182  on 11/07/2024 at 07:56 AM EST</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Scott Kapulskey, MD</td><td align="right"><span class="bold">Date: </span>11/05/2024</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 11/07/2024 03:44 PM EST</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id12" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="11">Depression screening</td><td rowspan="11">PHQ-9</td><td>Little interest or pleasure in doing things: Several days</td><td/></tr><tr><td>Feeling down, depressed, or hopeless: Several days</td><td/></tr><tr><td>Trouble falling or staying asleep, or sleeping too much: More than half the days</td><td/></tr><tr><td>Feeling tired or having little energy: Several days</td><td/></tr><tr><td>Poor appetite or overeating: Not at all</td><td/></tr><tr><td>Feeling bad about yourself or that you are a failure, or have let yourself or your family down: Not at all</td><td/></tr><tr><td>Trouble concentrating on things, such as reading the newspaper or watching television: Not at all</td><td/></tr><tr><td>Moving or speaking so slowly that other people could have noticed; or the opposite, being so fidgety or restless that you have been moving around a lot more than usual: Not at all</td><td/></tr><tr><td>Thoughts that you would be better off dead or of hurting yourself in some way: Not at all</td><td/></tr><tr><td>Total Score: 5</td><td/></tr><tr><td>Interpretation: Mild Depression</td><td/></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="11">General Examination</td><td>General appearance:</td><td colspan="2">alert, pleasant, obese and nourished and in no acute distress, cries easily</td></tr><tr><td>Head:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Neck / thyroid:</td><td colspan="2">supple, no cervical lymphadenopathy , carotid pulses are normal and without bruits</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Abdomen:</td><td colspan="2">soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly</td></tr><tr><td>Neurologic:</td><td colspan="2">normal upper and lower extremity motor strength and function, cooperative with exam, arises from a chair and initiates gait in a stable fashion.</td></tr><tr><td>Back:</td><td colspan="2">Left-sided hematoma in the posterior axillary line, also seen along the same line in the left iliac crest from the fall</td></tr><tr><td>Musculoskeletal:</td><td colspan="2">Heberden's nodes of the DIP of the hands  bilaterally. Decreased range of motion with abduction and internal rotation of the shoulders left greater than right.</td></tr><tr><td>Psych:</td><td colspan="2">cooperative with exam, with good judgement and insight, with no auditory or visual hallucinations, thought process is logical and goal directed without suicidal ideation or delusions</td></tr><tr><td>HEENT</td><td colspan="2">Extraocular movements are intact.  Conjunctive a pink and moist</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>